» Articles » PMID: 35757725

Thymus Functionality Needs More Than a Few TECs

Overview
Journal Front Immunol
Date 2022 Jun 27
PMID 35757725
Authors
Affiliations
Soon will be listed here.
Abstract

The thymus, a primary lymphoid organ, produces the T cells of the immune system. Originating from the 3 pharyngeal pouch during embryogenesis, this organ functions throughout life. Yet, thymopoiesis can be transiently or permanently damaged contingent on the types of systemic stresses encountered. The thymus also undergoes a functional decline during aging, resulting in a progressive reduction in naïve T cell output. This atrophy is evidenced by a deteriorating thymic microenvironment, including, but not limited, epithelial-to-mesenchymal transitions, fibrosis and adipogenesis. An exploration of cellular changes in the thymus at various stages of life, including mouse models of in-born errors of immunity and with single cell RNA sequencing, is revealing an expanding number of distinct cell types influencing thymus functions. The thymus microenvironment, established through interactions between immature and mature thymocytes with thymus epithelial cells (TEC), is well known. Less well appreciated are the contributions of neural crest cell-derived mesenchymal cells, endothelial cells, diverse hematopoietic cell populations, adipocytes, and fibroblasts in the thymic microenvironment. In the current review, we will explore the contributions of the many stromal cell types participating in the formation, expansion, and contraction of the thymus under normal and pathophysiological processes. Such information will better inform approaches for restoring thymus functionality, including thymus organoid technologies, beneficial when an individuals' own tissue is congenitally, clinically, or accidentally rendered non-functional.

Citing Articles

, or spaceflight-induced thymic involution.

Muramatsu W, Maryanovich M, Akiyama T, Karagiannis G Front Immunol. 2025; 15:1534444.

PMID: 39926601 PMC: 11802524. DOI: 10.3389/fimmu.2024.1534444.


Dynamics of somatostatin 4 receptor expression during chronic-stress loading and its potential as a chronic-stress marker.

Abe Y, Murase T, Mitsuma M, Shinba Y, Yamashita H, Ikematsu K Sci Rep. 2024; 14(1):10045.

PMID: 38698013 PMC: 11066077. DOI: 10.1038/s41598-024-58621-7.


Whole-transcriptome profiling reveals potential biomarkers for the reversal of thymic epithelial cell senescence by umbilical cord mesenchymal stem cells.

Yang Z, Tian C, He J, Pan H, Ruan G, Zhao J Aging (Albany NY). 2024; 16(8):7009-7021.

PMID: 38637117 PMC: 11087093. DOI: 10.18632/aging.205738.


Transcriptional profile of human thymus reveals IGFBP5 is correlated with age-related thymic involution.

Yang X, Chen X, Wang W, Qu S, Lai B, Zhang J Front Immunol. 2024; 15:1322214.

PMID: 38318192 PMC: 10839013. DOI: 10.3389/fimmu.2024.1322214.


Clinical features of myasthenia gravis with neurological and systemic autoimmune diseases.

Zhu Y, Wang B, Hao Y, Zhu R Front Immunol. 2023; 14:1223322.

PMID: 37781409 PMC: 10538566. DOI: 10.3389/fimmu.2023.1223322.


References
1.
Bhalla P, Wysocki C, van Oers N . Molecular Insights Into the Causes of Human Thymic Hypoplasia With Animal Models. Front Immunol. 2020; 11:830. PMC: 7214791. DOI: 10.3389/fimmu.2020.00830. View

2.
Bleul C, Corbeaux T, Reuter A, Fisch P, Monting J, Boehm T . Formation of a functional thymus initiated by a postnatal epithelial progenitor cell. Nature. 2006; 441(7096):992-6. DOI: 10.1038/nature04850. View

3.
Burnley P, Rahman M, Wang H, Zhang Z, Sun X, Zhuge Q . Role of the p63-FoxN1 regulatory axis in thymic epithelial cell homeostasis during aging. Cell Death Dis. 2013; 4:e932. PMC: 3847336. DOI: 10.1038/cddis.2013.460. View

4.
Passos G, Speck-Hernandez C, Assis A, Mendes-da-Cruz D . Update on Aire and thymic negative selection. Immunology. 2017; 153(1):10-20. PMC: 5721245. DOI: 10.1111/imm.12831. View

5.
Bosticardo M, Pala F, Calzoni E, Delmonte O, Dobbs K, Gardner C . Artificial thymic organoids represent a reliable tool to study T-cell differentiation in patients with severe T-cell lymphopenia. Blood Adv. 2020; 4(12):2611-2616. PMC: 7322962. DOI: 10.1182/bloodadvances.2020001730. View